Olema Pharmaceuticals Inc
NASDAQ:OLMA
Olema Pharmaceuticals Inc
NASDAQ:OLMA
Price:
23.76
USD
-1.82%
Market Cap:
$1.9B
Balance Sheet
Balance Sheet Decomposition
Olema Pharmaceuticals Inc
Olema Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Olema Pharmaceuticals Inc
Olema Pharmaceuticals Inc
Balance Sheet
Olema Pharmaceuticals Inc
Olema Pharmaceuticals Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
3
|
0
|
339
|
14
|
24
|
69
|
139
|
|
| Cash Equivalents |
3
|
0
|
339
|
14
|
24
|
69
|
139
|
|
| Short-Term Investments |
0
|
0
|
0
|
273
|
181
|
193
|
295
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
|
| Other Current Assets |
0
|
0
|
4
|
3
|
4
|
4
|
2
|
|
| Total Current Assets |
3
|
0
|
342
|
291
|
209
|
267
|
438
|
|
| PP&E Net |
0
|
0
|
0
|
5
|
4
|
3
|
2
|
|
| PP&E Gross |
0
|
0
|
0
|
5
|
4
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
1
|
3
|
7
|
10
|
|
| Total Assets |
3
N/A
|
0
-97%
|
343
+342 600%
|
296
-14%
|
216
-27%
|
277
+28%
|
451
+63%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
1
|
1
|
0
|
0
|
3
|
4
|
|
| Accrued Liabilities |
0
|
0
|
4
|
9
|
16
|
19
|
37
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
5
|
9
|
17
|
22
|
42
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
2
|
2
|
1
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+600%
|
5
+229%
|
11
+148%
|
18
+59%
|
23
+27%
|
42
+82%
|
|
| Equity | ||||||||
| Common Stock |
9
|
9
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
6
|
11
|
33
|
104
|
209
|
306
|
435
|
|
| Additional Paid In Capital |
0
|
0
|
371
|
389
|
408
|
559
|
844
|
|
| Other Equity |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Total Equity |
3
N/A
|
1
N/A
|
338
N/A
|
285
-16%
|
198
-31%
|
254
+29%
|
409
+61%
|
|
| Total Liabilities & Equity |
3
N/A
|
0
-97%
|
343
+342 600%
|
296
-14%
|
216
-27%
|
277
+28%
|
451
+63%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
39
|
39
|
39
|
40
|
40
|
55
|
74
|
|
Switch to:
Switch to:
See Also
Discover More
